Shenzhen Kangtai Biological Products Co (SZSE:300601) Receivables Turnover : 0.16 (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Kangtai Biological Products Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Shenzhen Kangtai Biological Products Co's Revenue for the three months ended in Mar. 2024 was ¥452 Mil. Shenzhen Kangtai Biological Products Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥2,752 Mil. Hence, Shenzhen Kangtai Biological Products Co's Receivables Turnover for the three months ended in Mar. 2024 was 0.16.

Shenzhen Kangtai Biological Products Co Receivables Turnover Historical Data

The historical data trend for Shenzhen Kangtai Biological Products Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Kangtai Biological Products Co Receivables Turnover Chart

Shenzhen Kangtai Biological Products Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Receivables Turnover

Get a 7-Day Free Trial

2.03

1.70

2.38

1.68

1.37

Shenzhen Kangtai Biological Products Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Receivables Turnover	Get a 7-Day Free Trial															0.31	0.38	0.27	0.37	0.16

Competitive Comparison of Shenzhen Kangtai Biological Products Co's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Kangtai Biological Products Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shenzhen Kangtai Biological Products Co's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Kangtai Biological Products Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Shenzhen Kangtai Biological Products Co's Receivables Turnover falls into.

Shenzhen Kangtai Biological Products Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Shenzhen Kangtai Biological Products Co's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

	Receivables Turnover (A: Dec. 2023 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2023 )	/ (	(Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )
=	3477.439	/ (	(2293.301	+	2787.608)	/	2 )
=	3477.439	/	2540.4545
=	1.37

Shenzhen Kangtai Biological Products Co's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

	Receivables Turnover (Q: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2024 )	/ (	(Accounts Receivable (Q: Dec. 2023 )	+	Accounts Receivable (Q: Mar. 2024 ))	/	count )
=	451.659	/ (	(2787.608	+	2715.699)	/	2 )
=	451.659	/	2751.6535
=	0.16

Shenzhen Kangtai Biological Products Co (SZSE:300601) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Shenzhen Kangtai Biological Products Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Shenzhen Kangtai Biological Products Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Kangtai Biological Products Co (SZSE:300601) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Kangtai Biological Products Co Ltd (SZSE:300601) » Definitions » Receivables Turnover

Traded in Other Exchanges

N/A

Address

No. 6 Kefa Road, Science and Technology Industrial Park, Nanshan District, Shenzhen, CHN, 518057

Website

http://www.biokangtai.com

Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.

Executives

Liu Jian Kai	Directors, executives
Tao Jin	Secretary Dong
Zheng Hai Fa	Directors, executives
Zhou Hui	Executives
Miao Xiang	Directors, executives
Wen Fei Dong	Director
Du Wei Min	Directors, executives
Lv Zhi Yun	Supervisors
Gan Jian Hui	Executives
Zhu Zheng Yu	Executives
Liu Qun	Executives
Li Tong	Executives
Yuan Li Ping	Director
Li Xiang Ming	Independent director

Shenzhen Kangtai Biological Products Co (SZSE:300601) Headlines

No Headlines